Compounded with
Semaglutide
FDA inspection/warning records identify semaglutide products.
Tirzepatide
FDA's April 2025 Form 483 identifies tirzepatide 10 mg/mL and 20 mg/mL products.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
PQ Pharmacy, LLC
FDA inspection/warning records identify semaglutide products.
FDA's April 2025 Form 483 identifies tirzepatide 10 mg/mL and 20 mg/mL products.
Product evidence does not establish current availability.
Regulatory compliance
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
not supported
Section 503B
The 2025 warning states that PQ registered under section 503B; the agent did not find PQ in the FDA current weekly list dated 2026-08-18, so current registration is not asserted.
Telehealth providers
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
FDA warning-letter/Form 483/current-503B and Florida license/action sources were checked. Multiple FDA actions were verified; Florida showed no discipline.
U.S. Food and Drug Administration · 2022-08-12
U.S. Food and Drug Administration · 2022-10-27
U.S. Food and Drug Administration · 2025-04-04
FDA observations addressed sterile production practices and listed semaglutide and tirzepatide products.
Status not statedU.S. Food and Drug Administration · 2025-08-08
U.S. Food and Drug Administration · 2025-10-10
FDA stated that products failed section 503B conditions and described insanitary conditions, CGMP violations, unapproved drugs and misbranding.
Status not statedNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
No superiority claim is made for review volume, ratings, or patient sentiment.
Located in Brooksville, Florida, PQ Pharmacy is a USP 800 and CGMP compliant FDA-Registered 503B Outsourcing Facility.
You registered your facility with the U.S. Food and Drug Administration (FDA) as an outsourcing facility under section 503B ... drug products you produced failed to meet the conditions of section 503B
Semaglutide 2.5mg/mL (2mL and 4mL vials) ... Tirzepatide 10mg/mL (1mL and 3mL vials) ... Tirzepatide 20mg/mL (3mL vials)
PQ PHARMACY, License Number: PH33659, License Status: Clear/, Qualifications: Special Sterile Compounding Outsourcing Facility ... Discipline on File: No
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 5 dated first-party or regulator citation(s), 5 regulatory/action record(s), and 4 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.